Insider Transactions in Q2 2024 at Aprea Therapeutics, Inc. (APRE)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2024
|
Bernd R. Seizinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+2.92%
|
-
|
|
Jun 20
2024
|
Marc Duey Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+0.5%
|
-
|
|
Jun 20
2024
|
Michael Grissinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+36.17%
|
-
|
|
Jun 20
2024
|
John B Henneman Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+10.22%
|
-
|
|
Jun 20
2024
|
Richard Peters Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+33.5%
|
-
|
|
Jun 20
2024
|
Rifat Pamukcu Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+19.19%
|
-
|
|
May 01
2024
|
Nadeem Q. Mirza Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,730
+50.0%
|
-
|